US Stock MarketDetailed Quotes

PTIX Protagenic Therapeutics

Watchlist

0.7600
+0.0348+4.80%

Close Jul 11 16:00 ET

3.38MMarket Cap-554P/E (TTM)

Protagenic Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Assets

Current assets

Cash, cash equivalents and short term investments

-68.32%2.42M

-49.16%4.06M

-35.33%5.27M

-31.86%6.04M

-21.82%7.65M

-23.07%7.98M

-24.89%8.15M

-25.68%8.87M

-Cash and cash equivalents

500.60%831.78K

498.49%1.29M

-3.15%153.33K

-35.21%219.44K

-71.28%138.49K

-60.24%215.19K

-65.59%158.32K

-97.16%338.67K

-Short-term investments

-78.81%1.59M

-64.34%2.77M

-35.96%5.12M

-31.73%5.82M

-19.25%7.51M

-21.02%7.76M

-23.09%7.99M

--8.53M

Prepaid assets

213.82%43.99K

152.95%144.03K

2.45%104.08K

498.16%874.67K

8.53%14.02K

-91.73%56.94K

-87.34%101.58K

13.21%146.23K

Total current assets

-67.80%2.47M

-47.73%4.2M

-34.86%5.38M

-23.26%6.92M

-21.78%7.66M

-27.34%8.04M

-29.19%8.25M

-25.27%9.01M

Non current assets

Net PPE

6,473.35%110.76K

6,848.28%123.33K

--55.98K

--1.6K

--1.69K

--1.78K

----

Total non current assets

6,473.35%110.76K

6,848.28%123.33K

--55.98K

--1.6K

--1.69K

--1.78K

--0

Total assets

-66.36%2.58M

-46.21%4.32M

-34.18%5.43M

-23.24%6.92M

-21.76%7.67M

-27.33%8.04M

-29.19%8.25M

-25.27%9.01M

Liabilities

Current liabilities

Payables

-37.70%108.95K

-26.81%113.8K

74.77%243.52K

-52.69%158.17K

-37.39%174.87K

-44.26%155.49K

-49.08%139.34K

80.97%334.3K

-accounts payable

-37.70%108.95K

-26.81%113.8K

74.77%243.52K

-52.69%158.17K

-37.39%174.87K

-44.26%155.49K

-49.08%139.34K

80.97%334.3K

Current accrued expenses

-52.38%337.15K

-12.69%541.45K

48.94%616.82K

639.89%952.91K

40.37%707.97K

19.13%620.15K

-8.13%414.14K

-69.18%128.79K

Current debt and capital lease obligation

----

--419.76K

--394.31K

--369.13K

--344.23K

----

-Current debt

----

--419.76K

--394.31K

--369.13K

--344.23K

----

Current liabilities

-64.37%446.1K

-41.49%655.25K

131.28%1.28M

225.08%1.51M

59.76%1.25M

40.06%1.12M

-23.60%553.48K

-23.15%463.09K

Non current liabilities

Long term debt and capital lease obligation

----

-43.29%318.78K

-55.65%293.32K

-Long term debt

----

-43.29%318.78K

-55.65%293.32K

Total non current liabilities

--0

-43.29%318.78K

-55.65%293.32K

Total liabilities

-64.37%446.1K

-41.49%655.25K

46.76%1.28M

99.02%1.51M

16.06%1.25M

0.17%1.12M

-32.20%872.26K

-40.16%756.41K

Shareholders'equity

Share capital

2.30%444

-74.90%434

-74.86%434

0.46%434

1.89%1.73K

6.20%1.73K

-common stock

2.30%444

-74.90%434

-74.86%434

0.46%434

1.89%1.73K

6.27%1.73K

-Preferred stock

--0

Retained earnings

-22.67%-32.5M

-19.40%-30.78M

-15.59%-29.1M

-14.24%-27.71M

-12.35%-26.5M

-16.00%-25.78M

-18.02%-25.18M

-18.57%-24.25M

Paid-in capital

3.53%34.72M

3.56%34.56M

2.11%33.87M

2.27%33.7M

2.56%33.54M

2.96%33.37M

4.07%33.17M

4.89%32.96M

Gains losses not affecting retained earnings

86.20%-86.77K

83.23%-113.55K

-0.43%-617.74K

-30.42%-586.46K

-57.44%-628.76K

-172.56%-676.91K

-256.84%-615.11K

-163.57%-449.68K

Total stockholders'equity

-66.75%2.13M

-46.97%3.67M

-43.75%4.15M

-34.44%5.41M

-26.44%6.41M

-30.42%6.92M

-28.82%7.38M

-23.52%8.26M

Total equity

-66.75%2.13M

-46.97%3.67M

-43.75%4.15M

-34.44%5.41M

-26.44%6.41M

-30.42%6.92M

-28.82%7.38M

-23.52%8.26M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments	-68.32%2.42M	-49.16%4.06M	-49.16%4.06M	-35.33%5.27M	-31.86%6.04M	-21.82%7.65M	-23.07%7.98M	-23.07%7.98M	-24.89%8.15M	-25.68%8.87M
-Cash and cash equivalents	500.60%831.78K	498.49%1.29M	498.49%1.29M	-3.15%153.33K	-35.21%219.44K	-71.28%138.49K	-60.24%215.19K	-60.24%215.19K	-65.59%158.32K	-97.16%338.67K
-Short-term investments	-78.81%1.59M	-64.34%2.77M	-64.34%2.77M	-35.96%5.12M	-31.73%5.82M	-19.25%7.51M	-21.02%7.76M	-21.02%7.76M	-23.09%7.99M	--8.53M
Prepaid assets	213.82%43.99K	152.95%144.03K	152.95%144.03K	2.45%104.08K	498.16%874.67K	8.53%14.02K	-91.73%56.94K	-91.73%56.94K	-87.34%101.58K	13.21%146.23K
Total current assets	-67.80%2.47M	-47.73%4.2M	-47.73%4.2M	-34.86%5.38M	-23.26%6.92M	-21.78%7.66M	-27.34%8.04M	-27.34%8.04M	-29.19%8.25M	-25.27%9.01M
Non current assets
Net PPE	6,473.35%110.76K	6,848.28%123.33K	6,848.28%123.33K	--55.98K	--1.6K	--1.69K	--1.78K	--1.78K	----	----
Total non current assets	6,473.35%110.76K	6,848.28%123.33K	6,848.28%123.33K	--55.98K	--1.6K	--1.69K	--1.78K	--1.78K	--0	--0
Total assets	-66.36%2.58M	-46.21%4.32M	-46.21%4.32M	-34.18%5.43M	-23.24%6.92M	-21.76%7.67M	-27.33%8.04M	-27.33%8.04M	-29.19%8.25M	-25.27%9.01M
Liabilities
Current liabilities
Payables	-37.70%108.95K	-26.81%113.8K	-26.81%113.8K	74.77%243.52K	-52.69%158.17K	-37.39%174.87K	-44.26%155.49K	-44.26%155.49K	-49.08%139.34K	80.97%334.3K
-accounts payable	-37.70%108.95K	-26.81%113.8K	-26.81%113.8K	74.77%243.52K	-52.69%158.17K	-37.39%174.87K	-44.26%155.49K	-44.26%155.49K	-49.08%139.34K	80.97%334.3K
Current accrued expenses	-52.38%337.15K	-12.69%541.45K	-12.69%541.45K	48.94%616.82K	639.89%952.91K	40.37%707.97K	19.13%620.15K	19.13%620.15K	-8.13%414.14K	-69.18%128.79K
Current debt and capital lease obligation	----	----	----	--419.76K	--394.31K	--369.13K	--344.23K	--344.23K	----	----
-Current debt	----	----	----	--419.76K	--394.31K	--369.13K	--344.23K	--344.23K	----	----
Current liabilities	-64.37%446.1K	-41.49%655.25K	-41.49%655.25K	131.28%1.28M	225.08%1.51M	59.76%1.25M	40.06%1.12M	40.06%1.12M	-23.60%553.48K	-23.15%463.09K
Non current liabilities
Long term debt and capital lease obligation	----	----	----	----	----	----	----	----	-43.29%318.78K	-55.65%293.32K
-Long term debt	----	----	----	----	----	----	----	----	-43.29%318.78K	-55.65%293.32K
Total non current liabilities	--0	--0	--0	--0	--0	--0	--0	--0	-43.29%318.78K	-55.65%293.32K
Total liabilities	-64.37%446.1K	-41.49%655.25K	-41.49%655.25K	46.76%1.28M	99.02%1.51M	16.06%1.25M	0.17%1.12M	0.17%1.12M	-32.20%872.26K	-40.16%756.41K
Shareholders'equity
Share capital	2.30%444	2.30%444	2.30%444	-74.90%434	-74.90%434	-74.86%434	0.46%434	0.46%434	1.89%1.73K	6.20%1.73K
-common stock	2.30%444	2.30%444	2.30%444	-74.90%434	-74.90%434	-74.86%434	0.46%434	0.46%434	1.89%1.73K	6.27%1.73K
-Preferred stock	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Retained earnings	-22.67%-32.5M	-19.40%-30.78M	-19.40%-30.78M	-15.59%-29.1M	-14.24%-27.71M	-12.35%-26.5M	-16.00%-25.78M	-16.00%-25.78M	-18.02%-25.18M	-18.57%-24.25M
Paid-in capital	3.53%34.72M	3.56%34.56M	3.56%34.56M	2.11%33.87M	2.27%33.7M	2.56%33.54M	2.96%33.37M	2.96%33.37M	4.07%33.17M	4.89%32.96M
Gains losses not affecting retained earnings	86.20%-86.77K	83.23%-113.55K	83.23%-113.55K	-0.43%-617.74K	-30.42%-586.46K	-57.44%-628.76K	-172.56%-676.91K	-172.56%-676.91K	-256.84%-615.11K	-163.57%-449.68K
Total stockholders'equity	-66.75%2.13M	-46.97%3.67M	-46.97%3.67M	-43.75%4.15M	-34.44%5.41M	-26.44%6.41M	-30.42%6.92M	-30.42%6.92M	-28.82%7.38M	-23.52%8.26M
Total equity	-66.75%2.13M	-46.97%3.67M	-46.97%3.67M	-43.75%4.15M	-34.44%5.41M	-26.44%6.41M	-30.42%6.92M	-30.42%6.92M	-28.82%7.38M	-23.52%8.26M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall